These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14602417)

  • 1. N-acylated chitosan: hydrophobic matrices for controlled drug release.
    Le Tien C; Lacroix M; Ispas-Szabo P; Mateescu MA
    J Control Release; 2003 Nov; 93(1):1-13. PubMed ID: 14602417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Hydrophilic Matrix Tablets for the Controlled Released of Chlorzoxazone.
    Creteanu A; Lisa G; Vasile C; Popescu MC; Pamfil D; Lungu CN; Panainte AD; Tantaru G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide.
    Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M
    Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels.
    Martin L; Wilson CG; Koosha F; Uchegbu IF
    Eur J Pharm Biopharm; 2003 Jan; 55(1):35-45. PubMed ID: 12551702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets.
    Macleod GS; Fell JT; Collett JH
    Int J Pharm; 1999 Oct; 188(1):11-8. PubMed ID: 10528078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure.
    Shu XZ; Zhu KJ
    Int J Pharm; 2002 Feb; 233(1-2):217-25. PubMed ID: 11897426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray-dried chitinosans. Part II: in vitro drug release from tablets made from spray-dried chitinosans.
    Rege PR; Garmise RJ; Block LH
    Int J Pharm; 2003 Feb; 252(1-2):53-9. PubMed ID: 12550780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan and its use as a pharmaceutical excipient.
    Illum L
    Pharm Res; 1998 Sep; 15(9):1326-31. PubMed ID: 9755881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of bupivacaine from devices based on chitosan.
    Bernardo MV; Blanco MD; Sastre RL; Teijón C; Teijón JM
    Farmaco; 2003 Nov; 58(11):1187-91. PubMed ID: 14572870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
    Fukuda M; Goto A
    Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heat on characteristics of chitosan film coated on theophylline tablets.
    Nunthanid J; Wanchana S; Sriamornsak P; Limmatavapirat S; Luangtana-anan M; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2002 Sep; 28(8):919-30. PubMed ID: 12378961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
    Bresolin JR; Largura MC; Dalri CC; Hoffer G; Rodrigues CA; Lucinda-Silva RM
    Drug Dev Ind Pharm; 2014 Apr; 40(4):503-10. PubMed ID: 23594298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release.
    Macleod GS; Collett JH; Fell JT
    J Control Release; 1999 Apr; 58(3):303-10. PubMed ID: 10099155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-derived polymer-surfactants and their micellar properties.
    Yoshioka H; Nonaka K; Fukuda K; Kazama S
    Biosci Biotechnol Biochem; 1995 Oct; 59(10):1901-4. PubMed ID: 8534983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels.
    Martin L; Wilson CG; Koosha F; Tetley L; Gray AI; Senel S; Uchegbu IF
    J Control Release; 2002 Apr; 80(1-3):87-100. PubMed ID: 11943390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation.
    Dhawan S; Singla AK
    Biotech Histochem; 2003 Oct; 78(5):243-54. PubMed ID: 14989642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro evaluation of chitosan matrices cross-linked by formaldehyde vapors.
    Rao BS; Murthy KV
    Drug Dev Ind Pharm; 2000 Oct; 26(10):1085-90. PubMed ID: 11028223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro evaluation of a film-controlled dosage form self-converted from monolithic tablet in gastrointestinal environment.
    Zhang T; Mao S; Sun W
    J Pharm Sci; 2010 Nov; 99(11):4678-90. PubMed ID: 20845465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.